PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma

Completed · Not applicable

Conditions studied: Sarcoma

In brief

RATIONALE: Diagnostic procedures, such as PET scan and CT scan, may help doctors determine the extent of cancer and predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying how well PET scan combined with CT scan evaluates treatment response in patients undergoing treatment for bone cancer or soft tissue sarcoma.

Key facts

Study ID

NCT00335751

Run by

Jonsson Comprehensive Cancer Center

People needed

120

Starts

2006-01-01

Expected to finish

2011-10-01

Last updated by the study team

2020-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically confirmed bone or soft tissue sarcoma
• Scheduled to undergo treatment (i.e., chemotherapy and/or radiotherapy) for sarcoma
• Negative pregnancy test
• Fertile patients must use effective contraception
• Not claustrophobic
• Able to lie supine for 1 hour
• Patients with diabetes mellitus allowed provided serum glucose levels ≤ 200 mg/dL

You may not qualify if…

• pregnant
• other malignancies within the past 5 years (except completely resected cervical or nonmelanoma skin cancer) unless the malignancy was curatively treated and is at low risk for recurrence

Where it is running

• Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.